3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
18
Hematologic Neoplasms
10
Prostatic Neoplasms
9
Colorectal Neoplasms
9
Breast Neoplasms
9
Hematopoietic and Lymphatic System Neoplasm
8
Carcinoma, Non-Small-Cell Lung
7
Anatomic Stage I Breast Cancer AJCC v8
7
Pancreatic Neoplasms
6
Neoplasm Metastasis
6
Uterine Cervical Neoplasms
5
Urinary Bladder Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Ovarian Neoplasms
4
Neoplasms
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Breast Carcinoma In Situ
4
Triple Negative Breast Neoplasms
3
Multiple Myeloma
3
Melanoma
3
Malignant Solid Neoplasm
3
Lymphoma
3
Leukemia, Myeloid, Acute
3
Carcinoma, Renal Cell
3
Stomach Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Papillomavirus Infections
2
Mouth Neoplasms
2
Head and Neck Neoplasms
2
Interventions
Gemcitabine
4
130-nm albumin-bound paclitaxel
4
Cetuximab
3
Bevacizumab
3
pembrolizumab
2
Pemetrexed
2
Paclitaxel
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Cisplatin
2
Carboplatin
2
Albumin-Bound Paclitaxel
2
relacorilant
1
Long Interspersed Nucleotide Elements
1
Immunotherapy, Adoptive
1
Floxuridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Pancreatic Ductal
×
Practice Guidelines as Topic
×
1 year
×
Clear all
No trials found.